Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Melatonin increases cashmere quality in goats but reduces their milk production and doesn't affect their offspring's hair growth.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The RORα gene is active in different parts of cashmere goat hair follicles and may be influenced by melatonin, especially in December when hair growth changes.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Check and treat low iron and vitamin D levels in people with hair loss.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Melatonin and cortisol affect mink winter hair growth, but β-endorphin levels do not.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The mFG score is effective for diagnosing hirsutism.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Different amounts of daylight affect cashmere growth in goats by changing the activity of certain genes and molecules.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.